0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Diagnostics Market Size, Status and Forecast 2021-2027
Published Date: June 2021
|
Report Code: QYRE-Auto-13Z613
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Influenza Diagnostics Market Size Status and Forecast 2021 2027

Global Influenza Diagnostics Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-13Z613
Report
June 2021
105 Pages
QYResearch
Region: Global, North America, China, Europe, Japan, France, Germany, South Korea, Italy, India, Taiwan, Australia, Thailand, Saudi Arabia, Turkey, Malaysia, Philippines, Indonesia,
Description
Table of Content
Tables & Figures

Influenza Diagnostics Market 

The global Influenza Diagnostics market size is projected to reach USD 3374.9 Million by 2027, from USD 2195.6 Million in 2020, at a CAGR of 6.3% during 2021-2027. Key drivers of the influenza diagnostics market include growing prevalence of influenza and increasing research for diagnostic technologies. Further growing awareness and the need for early detection of the disease is also fuelling the growth of the influenza diagnostics market during the forecast period. Moreover, the emergence of covid 19 has upped the use of influenza diagnostic kits due to similarities shared between the two diseases and easy approvals is leading companies to create presence in global markets ultimately surging the market growth.

Influenza diagnostics market size

Trends Influencing the Global Influenza Diagnostics Market 

Growing prevalence of influenza and increasing research for diagnostic technologies

Influenza is a leading cause for morbidity and mortality in the general human population. Several initiatives and research funding are being done to develop diagnostic technologies for tackling the influenza virus. These new tools based on genomic and proteomic technologies help detect the viruses, deliver better surveillance and diagnose the disease quickly. Scientists are able to focus efficiently on areas such as vaccine development and other therapeutic strategies. Thus growing prevalence of influenza and rapid developments in diagnostic technologies is expected to fuel the growth of the influenza diagnostics market during the forecast period.

Growing awareness and the need for early detection of disease

There is a growing awareness regarding the virus. Organizations are keen on promoting early detection and diagnosis of the disease for eliminating influenza related death. RIDT( Rapid Influenza Diagnostic Testing) is cost efficient and has the ability to provide test results under 15 to 30 minutes making it the most preferred choice for testing. Thus increasing awareness and the need for early detection is forcing organizations to take steps to prevent the disease thereby propeling the growth of the influenza diagnostics market in the coming years.

Advent of covid 19 and easy approval

Influenza A, B virus and covid 19 have similar symptoms in the form of respiratory illness. Covid gained dominance during the influenza season in the months of December and February. This has surged the use of influenza diagnostics kits increasing the growth of the market during the forecast period. Moreover companies are obtaining CLIA waiver approvals for test kits and tools which will help in enhancing their presence in global markets ultimately accelerating the growth of the influenza diagnostics market.

Influenza Diagnostics Market Share Analysis

Based on region, North America is expected to provide lucrative opportunities for growth in the influenza diagnostics market share during the forecast period due to growing research on diagnostic technologies for early detection of rising rising influenza cases.

Based on type, RIDTs( Rapid Influenza Diagnostic Tests) is expected to provide lucrative opportunities for growth in the influenza diagnostics market share due to their easy usage and fast results. RIDTs have also gained approval for workplace and bedside usage. It can also be used where point of care testing is required.

Based on application, the hospitals segment is expected to provide lucrative opportunities for growth in the influenza diagnostics market share. However point of care testing(POCT) will grow the fastest due to their easy use design.

Influenza Diagnostics Market Segmentation

By Type

  • RIDT
  • RT-PCR
  • Cell Culture
  • Others

By Application

  • Hospitals
  • POCT
  • Others

By Region

  • North America
  • US.
  • Canada
  • Europe
  • Germany
  • France
  • UK.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA 

By Companies

  • BD
  • Abbott (Include Alere)
  • Roche
  • SIEMENS
  • Analytik Jena
  • Quidel
  • Thermo Fisher
  • Meridian Bioscience
  • BioMerieux
  • Sekisui Diagnostics
  • Response Biomedical
  • SA Scientific

Scope of Influenza Diagnostics Market Report

Report Metric

Details

Report Name

Influenza Diagnostics Market

Market size value in 2020

USD 2195.6 Million

Revenue forecast in 2027

USD 3374.9 Million

Growth Rate

CAGR 6.3%

Base year considered

2020

Forecast Period

2021-2027

By Type

RIDT, RT-PCR, Cell Culture

By Application

Hospitals, POCT

Report Coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

 Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How big is the Influenza Diagnostics market?

Ans. The global Influenza Diagnostics market size is projected to reach US$ 3374.9 million by 2027, from US$ 2195.6 million in 2020, at a CAGR of 6.3% during 2021-2027.

2. Who are the major producers in the Influenza diagnostics industry?

Ans. The major producers in this industry are BD, Abbott (Include Alere) and Roche, whose combined revenue ratio in 2019 is 50.61%.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2016-2027)
2.2 Influenza Diagnostics Growth Trends by Regions
2.2.1 Influenza Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Diagnostics Industry Dynamic
2.3.1 Influenza Diagnostics Market Trends
2.3.2 Influenza Diagnostics Market Drivers
2.3.3 Influenza Diagnostics Market Challenges
2.3.4 Influenza Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Diagnostics Players by Revenue
3.1.1 Global Top Influenza Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2020
3.5 Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Diagnostics Breakdown Data by Type
4.1 Global Influenza Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027)
5 Influenza Diagnostics Breakdown Data by Application
5.1 Global Influenza Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Influenza Diagnostics Market Size (2016-2027)
6.2 North America Influenza Diagnostics Market Size by Type
6.2.1 North America Influenza Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Influenza Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Influenza Diagnostics Market Size by Type (2016-2027)
6.3 North America Influenza Diagnostics Market Size by Application
6.3.1 North America Influenza Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Influenza Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Influenza Diagnostics Market Size by Application (2016-2027)
6.4 North America Influenza Diagnostics Market Size by Country
6.4.1 North America Influenza Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Influenza Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Influenza Diagnostics Market Size (2016-2027)
7.2 Europe Influenza Diagnostics Market Size by Type
7.2.1 Europe Influenza Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Influenza Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Influenza Diagnostics Market Size by Type (2016-2027)
7.3 Europe Influenza Diagnostics Market Size by Application
7.3.1 Europe Influenza Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Influenza Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Influenza Diagnostics Market Size by Application (2016-2027)
7.4 Europe Influenza Diagnostics Market Size by Country
7.4.1 Europe Influenza Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Influenza Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Influenza Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Influenza Diagnostics Market Size by Type
8.2.1 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Diagnostics Market Size by Application
8.3.1 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Diagnostics Market Size by Region
8.4.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Influenza Diagnostics Market Size (2016-2027)
9.2 Latin America Influenza Diagnostics Market Size by Type
9.2.1 Latin America Influenza Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Influenza Diagnostics Market Size by Application
9.3.1 Latin America Influenza Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Influenza Diagnostics Market Size by Country
9.4.1 Latin America Influenza Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Influenza Diagnostics Market Size by Type
10.2.1 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Diagnostics Market Size by Application
10.3.1 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Diagnostics Market Size by Country
10.4.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Influenza Diagnostics Introduction
11.1.4 BD Revenue in Influenza Diagnostics Business (2016-2021)
11.1.5 BD Recent Development
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Details
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021)
11.2.5 Abbott (Include Alere) Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Influenza Diagnostics Introduction
11.3.4 Roche Revenue in Influenza Diagnostics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 SIEMENS
11.4.1 SIEMENS Company Details
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Influenza Diagnostics Introduction
11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2016-2021)
11.4.5 SIEMENS Recent Development
11.5 Analytik Jena
11.5.1 Analytik Jena Company Details
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Influenza Diagnostics Introduction
11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021)
11.5.5 Analytik Jena Recent Development
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Influenza Diagnostics Introduction
11.6.4 Quidel Revenue in Influenza Diagnostics Business (2016-2021)
11.6.5 Quidel Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Influenza Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021)
11.7.5 Thermo Fisher Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021)
11.8.5 Meridian Bioscience Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Influenza Diagnostics Introduction
11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2016-2021)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Influenza Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Details
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Influenza Diagnostics Introduction
11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2016-2021)
11.12.5 SA Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of RIDT
    Table 3. Key Players of RT-PCR
    Table 4. Key Players of Cell Culture
    Table 5. Key Players of Others
    Table 6. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Influenza Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Influenza Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Influenza Diagnostics Market Share by Regions (2016-2021)
    Table 10. Global Influenza Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Influenza Diagnostics Market Share by Regions (2022-2027)
    Table 12. Influenza Diagnostics Market Trends
    Table 13. Influenza Diagnostics Market Drivers
    Table 14. Influenza Diagnostics Market Challenges
    Table 15. Influenza Diagnostics Market Restraints
    Table 16. Global Influenza Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Influenza Diagnostics Market Share by Players (2016-2021)
    Table 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020)
    Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Influenza Diagnostics Product Solution and Service
    Table 23. Date of Enter into Influenza Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021)
    Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Influenza Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Influenza Diagnostics Revenue Market Share by Application (2016-2021)
    Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Influenza Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
    Table 63. BD Company Details
    Table 64. BD Business Overview
    Table 65. BD Influenza Diagnostics Product
    Table 66. BD Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 67. BD Recent Development
    Table 68. Abbott (Include Alere) Company Details
    Table 69. Abbott (Include Alere) Business Overview
    Table 70. Abbott (Include Alere) Influenza Diagnostics Product
    Table 71. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 72. Abbott (Include Alere) Recent Development
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche Influenza Diagnostics Product
    Table 76. Roche Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 77. Roche Recent Development
    Table 78. SIEMENS Company Details
    Table 79. SIEMENS Business Overview
    Table 80. SIEMENS Influenza Diagnostics Product
    Table 81. SIEMENS Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 82. SIEMENS Recent Development
    Table 83. Analytik Jena Company Details
    Table 84. Analytik Jena Business Overview
    Table 85. Analytik Jena Influenza Diagnostics Product
    Table 86. Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 87. Analytik Jena Recent Development
    Table 88. Quidel Company Details
    Table 89. Quidel Business Overview
    Table 90. Quidel Influenza Diagnostics Product
    Table 91. Quidel Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 92. Quidel Recent Development
    Table 93. Thermo Fisher Company Details
    Table 94. Thermo Fisher Business Overview
    Table 95. Thermo Fisher Influenza Diagnostics Product
    Table 96. Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 97. Thermo Fisher Recent Development
    Table 98. Meridian Bioscience Company Details
    Table 99. Meridian Bioscience Business Overview
    Table 100. Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 101. Meridian Bioscience Recent Development
    Table 102. BioMerieux Company Details
    Table 103. BioMerieux Business Overview
    Table 104. BioMerieux Influenza Diagnostics Product
    Table 105. BioMerieux Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 106. BioMerieux Recent Development
    Table 107. Sekisui Diagnostics Company Details
    Table 108. Sekisui Diagnostics Business Overview
    Table 109. Sekisui Diagnostics Influenza Diagnostics Product
    Table 110. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 111. Sekisui Diagnostics Recent Development
    Table 112. Response Biomedical Company Details
    Table 113. Response Biomedical Business Overview
    Table 114. Response Biomedical Influenza Diagnostics Product
    Table 115. Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 116. Response Biomedical Recent Development
    Table 117. SA Scientific Company Details
    Table 118. SA Scientific Business Overview
    Table 119. SA Scientific Influenza Diagnostics Product
    Table 120. SA Scientific Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
    Table 121. SA Scientific Recent Development
    Table 122. Research Programs/Design for This Report
    Table 123. Key Data Information from Secondary Sources
    Table 124. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Influenza Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. RIDT Features
    Figure 3. RT-PCR Features
    Figure 4. Cell Culture Features
    Figure 5. Others Features
    Figure 6. Global Influenza Diagnostics Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. POCT Case Studies
    Figure 9. Others Case Studies
    Figure 10. Influenza Diagnostics Report Years Considered
    Figure 11. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Influenza Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Influenza Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 14. Global Influenza Diagnostics Market Share by Regions (2022-2027)
    Figure 15. Global Influenza Diagnostics Market Share by Players in 2020
    Figure 16. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2020
    Figure 18. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 19. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 20. North America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Influenza Diagnostics Market Share by Type (2016-2027)
    Figure 22. North America Influenza Diagnostics Market Share by Application (2016-2027)
    Figure 23. North America Influenza Diagnostics Market Share by Country (2016-2027)
    Figure 24. United States Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Influenza Diagnostics Market Share by Type (2016-2027)
    Figure 28. Europe Influenza Diagnostics Market Share by Application (2016-2027)
    Figure 29. Europe Influenza Diagnostics Market Share by Country (2016-2027)
    Figure 30. Germany Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Influenza Diagnostics Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Influenza Diagnostics Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Influenza Diagnostics Market Share by Region (2016-2027)
    Figure 40. China Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Influenza Diagnostics Market Share by Type (2016-2027)
    Figure 48. Latin America Influenza Diagnostics Market Share by Application (2016-2027)
    Figure 49. Latin America Influenza Diagnostics Market Share by Country (2016-2027)
    Figure 50. Mexico Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Influenza Diagnostics Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Influenza Diagnostics Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Influenza Diagnostics Market Share by Country (2016-2027)
    Figure 56. Turkey Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. BD Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 60. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 61. Roche Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 62. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 63. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 64. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 65. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 66. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 67. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 68. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 69. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 70. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Oral Polio Vaccines OPV Market Insights and Forecast to 2028
Global Oral Polio Vaccines (OPV) Market Insights and Forecast to 2028

Market Analysis and Insights Global Oral Polio Vaccines OPV MarketDue to the COVID19 pandemic the global Oral Polio Vaccines OPV market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-12M3675
Wed Feb 09 00:00:00 UTC 2022

Add to Cart

Global Cutaneous and Systemic Leishmaniasis Drugs Market Insights and Forecast to 2028
Global Cutaneous and Systemic Leishmaniasis Drugs Market Insights and Forecast to 2028

Cutaneous and Systemic Leishmaniasis is the most common syndrome and can produce ulcers that have the potential of stimulating a periosteal reaction if the ulcer occurs near bone.Market Analysis and Insights Global Cutaneous and Systemic Leishmaniasis Drugs MarketThe global Cutaneous and Systemic Leishmaniasis Drugs market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Pentavalent Antimonials accounting for of the Cutaneous and Systemic Leishmaniasis Drugs global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-6C9857
Fri Feb 04 00:00:00 UTC 2022

Add to Cart

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Insights and Forecast to 2028
Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Insights and Forecast to 2028

Market Analysis and Insights Global Hepatitis B Virus Core Antibody Diagnostic Kits MarketDue to the COVID19 pandemic the global Hepatitis B Virus Core Antibody Diagnostic Kits market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Fri Feb 04 00:00:00 UTC 2022

Add to Cart

Global Hepatitis Test Kits Market Insights Forecast to 2028
Global Hepatitis Test Kits Market Insights, Forecast to 2028

Market Analysis and Insights Global Hepatitis Test Kits MarketDue to the COVID19 pandemic the global Hepatitis Test Kits market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-31V3504
Fri Feb 04 00:00:00 UTC 2022

Add to Cart